One thing I have noticed at some of the support groups I run is that there seems to be a very uneven distribution of when men start taking Zoledronic Acid (ZA). Hormone therapy (ADT) has many negative side effects and the loss of bone mineral density (thinning of the bones) that ZA (and similar drugs) [...]
When I had my prostate cancer recurrence it was characterized by a PSA in the mid 80s and a few positive lymph nodes showing on scans. My situation (oligo-recurrent prostate cancer) was described in a recent literature review called Salvage Therapy of Small Volume Prostate Cancer Nodal Failures: A Review of the Literature. The review [...]
When I opened my computer this afternoon I checked the Malecare prostate cancer crowd-funding site to see how things were going. To my great pleasure I discovered that Start A Cure (www.StartACure.org) had achieved it first funding success! Sometime in the early afternoon some very kind individual made the pledge that completed the funding goal [...]
Better prediction tools to predict treatment outcome in men with metastatic castration-resistant prostate cancer (mCRPC) should significantly improve treatment outcomes. Without good predictive measures we often don't know when is the optimum time to stop a therapy and move to another. This means that we might maturely stop an effective treatment losing the effectiveness of [...]
When I was diagnosed with a prostate cancer recurrence I was at the young age of 55 years. I live in New York City where there are a number of face-to-face support groups for prostate cancer, but none had any other men with advanced disease. At a support group run by Malecare I finally lost [...]